Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn moreDeveloping IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn moreDeveloping IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn moreDeveloping IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn moreInterested in learning more about how IQVIA can create solutions to help you drive healthcare forward?
OverviewAs part of the global healthcare community, IQVIA Belgium and its BIDS team (Business Intelligence and Data Science) continuously invest in ways to help life science companies find the next breakthrough in improving human health.
OverviewGiven the dynamic marketplace, your need to rely on sound information has never been greater. You must make fast decisions without delay. Innovate without undue risk. Execute without faltering.
OverviewWe can help you get your product to patients quickly. This is done by finding the right candidates to help you in assembling a qualitative team that is trained and equipped with the best tools & applications. With the unique IQVIA approach, we can also make sure you target the right healthcare providers.
OverviewIQVIA helps our customers generate real world evidence (RWE) to unlock the value of their investment at every stage of the product life cycle.
OverviewLet yourself be guided and get in direct contact with your key partners in your market. With IQVIA Pharm In Touch, IQVIA Dental In Touch, IQVIA MobiRep and integrated services, you will have even more freedom of movement.
OverviewIQVIA helps our customers generate real world evidence (RWE) to unlock the value of their investment at every stage of the product life cycle.
OverviewAs the essential partner for pharmacists and pharmaceutical companies we offer effective activation services and marketing tools to meet today's challenges. The Activation Services department of IQVIA is specialised in pharmacy communication and puts its expertise at the service of its partners.
OverviewReimagine clinical development by intelligently connecting data, technology and analytics to optimize your trials. The result? Faster decision making, innovation with reduced risk and driving trials without compromise so you can deliver life-changing therapies faster.
OverviewIQVIA is a world leader in using data, technology, advanced analytics and human expertise.
OverviewWhy work at IQVIA Belux? Help create a healthier world—start right here where we offer a diverse selection of opportunities.
Learn moreWe understand that part of your role involves spending a lot of time on the road, which is why at IQVIA we give you the opportunity to schedule your own agenda.
Learn moreOver the past few years, the MedTech industry has witnessed significant growth and development. An aging population, the rising burden of chronic diseases and increased trust in medical devices by clinicians and consumers have resulted in greater alliances between pharmaceutical companies and the MedTech sector.
Although North America and Europe currently hold 68% of the global MedTech market share, MedTech companies are now shifting their focus to emerging regions for R&D of new medical devices.
The MedTech industry is facing increasing challenges, such as an ever-changing regulatory environment, reimbursement cuts, the high cost of advanced medical technologies and safety pressures. The UK MedTech market, for example, is likely to be negatively impacted by the outcomes of Brexit. Consequently, innovative developments in MedTech have become crucial for sustaining health, as technology plays a key role in every aspect of our daily lives.
In a new White Paper on The Rise of Global Medical Technology, we provide an overview of the global MedTech industry, including market trends, drivers and barriers, the impact of a changing regulatory environment, key participants of the MedTech industry and an outlook with regional and therapeutic-area forecasts. The paper also offers insight into the most critical opportunities and risks that device firms should consider when bringing new technologies to the market. Download the full report and register to our newsletter to get monthly updates on interesting events, industry insights, thought leaderships and sales trends.